Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 7YCN | 7YCN | Crystal structure of SARS-CoV-2 Spike RBD in complex with IY-2A Fab | |
| 7DJZ | 7DJZ | Crystal structure of SARS-CoV-2 Spike RBD in complex with MW01 Fab | |
| 7DJZ | P0DTC2 | Crystal structure of SARS-CoV-2 Spike RBD in complex with MW01 Fab | |
| 7DK0 | 7DK0 | Crystal structure of SARS-CoV-2 Spike RBD in complex with MW05 Fab | |
| 7DK0 | P0DTC2 | Crystal structure of SARS-CoV-2 Spike RBD in complex with MW05 Fab | |
| 7DPM | 7DPM | Crystal structure of SARS-CoV-2 Spike RBD in complex with MW06 Fab | |
| 7DPM | P0DTC2 | Crystal structure of SARS-CoV-2 Spike RBD in complex with MW06 Fab | |
| 7DK2 | 7DK2 | Crystal structure of SARS-CoV-2 Spike RBD in complex with MW07 Fab | |
| 7DK2 | P0DTC2 | Crystal structure of SARS-CoV-2 Spike RBD in complex with MW07 Fab | |
| 7F5R | 7F5R | Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2 | |
| 7F5R | P0DTC2 | Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2 | |
| 7CHS | P0DTC2 | Crystal structure of SARS-CoV-2 antibody P22A-1D1 with RBD | |
| 7CHS | 7CHS | Crystal structure of SARS-CoV-2 antibody P22A-1D1 with RBD | |
| 7CDJ | P0DTC2 | Crystal structure of SARS-CoV-2 antibody P2C-1A3 with RBD | |
| 7CDJ | 7CDJ | Crystal structure of SARS-CoV-2 antibody P2C-1A3 with RBD | |
| 7CDI | P0DTC2 | Crystal structure of SARS-CoV-2 antibody P2C-1F11 with RBD | |
| 7CDI | 7CDI | Crystal structure of SARS-CoV-2 antibody P2C-1F11 with RBD | |
| 7E8M | P0DTC2 | Crystal structure of SARS-CoV-2 antibody P2C-1F11 with mutated RBD | |
| 7E8M | 7E8M | Crystal structure of SARS-CoV-2 antibody P2C-1F11 with mutated RBD | |
| 7CHO | P0DTC2 | Crystal structure of SARS-CoV-2 antibody P5A-1D2 with RBD | |
| 7CHO | 7CHO | Crystal structure of SARS-CoV-2 antibody P5A-1D2 with RBD | |
| 7CHP | P0DTC2 | Crystal structure of SARS-CoV-2 antibody P5A-3C8 with RBD | |
| 7CHP | 7CHP | Crystal structure of SARS-CoV-2 antibody P5A-3C8 with RBD | |
| 8I5H | P0DTC2 | Crystal structure of SARS-CoV-2 delta variant spike receptor-binding domain (RBD) in complex with NCV2SG48 Fab | |
| 8I5H | 8I5H | Crystal structure of SARS-CoV-2 delta variant spike receptor-binding domain (RBD) in complex with NCV2SG48 Fab | |
| 7WHH | Q9BYF1 | Crystal structure of SARS-CoV-2 omicron RBD and human ACE2 | |
| 7WHH | P0DTC2 | Crystal structure of SARS-CoV-2 omicron RBD and human ACE2 | |
| 7FBK | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain N501Y mutant in complex with neutralizing nanobody 20G6 | |
| 7FBK | 7FBK | Crystal structure of SARS-CoV-2 receptor binding domain N501Y mutant in complex with neutralizing nanobody 20G6 | |
| 7KN5 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobodies VHH E and U | |
| 7KN5 | 7KN5 | Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobodies VHH E and U | |
| 7KN6 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobody VHH V and antibody Fab CC12.3 | |
| 7KN6 | 7KN6 | Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobody VHH V and antibody Fab CC12.3 | |
| 7KN7 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobody VHH W and antibody Fab CC12.3 | |
| 7KN7 | 7KN7 | Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobody VHH W and antibody Fab CC12.3 | |
| 8FAH | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with SARS-CoV-2 reactive human antibody CR3022 | |
| 8FAH | 8FAH | Crystal structure of SARS-CoV-2 receptor binding domain in complex with SARS-CoV-2 reactive human antibody CR3022 | |
| 6XC3 | 6XC3 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.1 and CR3022 | |
| 6XC3 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.1 and CR3022 | |
| 6XC7 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.3 and CR3022 | |
| 6XC7 | 6XC7 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.3 and CR3022 | |
| 7LOP | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV05-163 and CR3022 | |
| 7LOP | 7LOP | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV05-163 and CR3022 | |
| 7LQ7 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV503 and COVA1-16 | |
| 7LQ7 | 7LQ7 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV503 and COVA1-16 | |
| 8GF2 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies eCR3022.20 and CC12.3 | |
| 8GF2 | 8GF2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies eCR3022.20 and CC12.3 | |
| 7Y3O | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody BIOLS56 | |
| 7Y3O | 7Y3O | Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody BIOLS56 | |
| 8F0I | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody COVA309-22 |
